Development trends and strategic landscape of cutting-edge biopharmaceuticalsLÜ Jianjun, CHEN Zhinan, BIAN Huijie937-944
Construction of patient-derived glioblastoma organoid models and sensitivity analysis of temozolomide and lomustine as monotherapy and in combinationYANG Guangzhao, ZOU Cheng, LIU Xiao, QIN Haozhe, PAN Jiahao, CAO Zhengcong, ZHANG Qi, LI Juan, GU Jintao, HE Yalong, LIN Wei945-952
Biodistribution and safety of intravenously administered oncolytic Newcastle disease virusLIU Man, LI Wenliang, FENG Lanting, LI Qian, WEI Ding, BIAN Huijie953-960
AI-driven de novo design and dynamic mechanistic study of peptide inhibitors targeting the SARS-CoV-2 membrane proteinTANG Qinjie, BAI Zhuohang, YANG Yuning, YANG Xiangmin, YANG Zhiwei, ZHANG Lei961-968,977
Comprehensive characterization of critical quality attributes of meplazumab for injectionYANG Tianyi, SONG Peiming, GUO Xiaobing, CHEN Xiaochun, TANG Hao969-977
Screening and functional validation of active natural products against osteoporosis based on osteoimmunologyZHANG Wenjuan, REN Tingting, JIANG Yao, BAI Wei, ZHAO Xin, ZHANG Genyang, QIAN Airong978-984
Platelet membrane biomimetic nanoparticles for lung-targeted gene delivery:construction and targeting evaluationWU Hongyan, HUI Wenting, QIAO Sai, LIU Miao, JI Qifeng, ZHOU Siyuan, LIU Daozhou985-992
Preparation,characterization,and in vivo muscle-promoting function of an anti-GDF8 monoclonal antibody(P249337)YU Duo, XIE Fei, ZHAO Bochen, HE Lei, LI Meng, LEI Xiaoying993-999,1007
Mouse model establishment and therapeutic evaluation of radiation-induced pulmonary fibrosisYANG Jiecheng, HOU Rong, YANG Liu, ZHANG Yang, WANG Ke1000-1007
Establishment and phenotypic analysis of an APP/PS1 mouse model with hepatic Kupffer cell depletionCHEN Shasha, LI Ziyue, SHI Jiayi, SONG Yuzhe, QIU Mangmang, GOU Xingchun1008-1016